LS
Leelyn Smith’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.41M | Buy |
99,337
+5,729
| +6% | +$139K | 0.4% | 74 |
|
|
2025
Q1 | $2.37M | Buy |
93,608
+5,841
| +7% | +$148K | 0.42% | 69 |
|
|
2024
Q4 | $2.33M | Buy |
87,767
+5,311
| +6% | +$141K | 0.41% | 71 |
|
|
2024
Q3 | $2.39M | Buy |
82,456
+5,382
| +7% | +$156K | 0.43% | 70 |
|
|
2024
Q2 | $2.16M | Buy |
77,074
+8,902
| +13% | +$249K | 0.42% | 66 |
|
|
2024
Q1 | $1.89M | Buy |
68,172
+4,978
| +8% | +$138K | 0.38% | 75 |
|
|
2023
Q4 | $1.82M | Buy |
63,194
+5,265
| +9% | +$152K | 0.4% | 66 |
|
|
2023
Q3 | $1.92M | Buy |
57,929
+4,347
| +8% | +$144K | 0.47% | 62 |
|
|
2023
Q2 | $1.97M | Sell |
53,582
-3,707
| -6% | -$136K | 0.47% | 60 |
|
|
2023
Q1 | $2.34M | Buy |
57,289
+1,461
| +3% | +$59.6K | 0.6% | 57 |
|
|
2022
Q4 | $2.86M | Buy |
55,828
+4,639
| +9% | +$238K | 0.79% | 36 |
|
|
2022
Q3 | $2.24M | Sell |
51,189
-53,753
| -51% | -$2.35M | 0.77% | 35 |
|
|
2022
Q2 | $5.5M | Buy |
104,942
+53,683
| +105% | +$2.81M | 1.43% | 15 |
|
|
2022
Q1 | $2.65M | Buy |
51,259
+1,017
| +2% | +$52.7K | 0.69% | 42 |
|
|
2021
Q4 | $2.97M | Sell |
50,242
-1,952
| -4% | -$115K | 0.79% | 31 |
|
|
2021
Q3 | $2.25M | Buy |
52,194
+485
| +0.9% | +$20.9K | 0.65% | 44 |
|
|
2021
Q2 | $2.03M | Buy |
51,709
+707
| +1% | +$27.7K | 0.6% | 50 |
|
|
2021
Q1 | $1.85M | Buy |
51,002
+3,978
| +8% | +$144K | 0.55% | 55 |
|
|
2020
Q4 | $1.73M | Buy |
47,024
+2,605
| +6% | +$95.9K | 0.55% | 55 |
|
|
2020
Q3 | $1.63M | Buy |
44,419
+618
| +1% | +$22.7K | 0.58% | 49 |
|
|
2020
Q2 | $1.43M | Buy |
43,801
+92
| +0.2% | +$3.01K | 0.59% | 46 |
|
|
2020
Q1 | $1.43M | Buy |
43,709
+5,896
| +16% | +$192K | 0.76% | 34 |
|
|
2019
Q4 | $1.48K | Buy |
+37,813
| New | +$1.48K | 0.71% | 37 |
|